Predictors of fetal growth in maternal HIV disease

American Journal of Perinatology

Volumn 27, Issue 7, 2010, Pages 517-523

  Iqbal, Sara N ^a   Kriebs, Jan ^a   Harman, Christopher ^a   Alger, Lindsay ^a   Kopelman, Jerome ^a   Turan, Ozhan ^a   Gungor, Sadettin ^a   Malinow, Andrew ^a   Baschat, Ahmet Alexander ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CD4 lymphocyte count; Fetal growth restriction; HIV; pregnancy

Indexed keywords

ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; FEMALE; FETUS; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; GROWTH INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRENATAL EXPOSURE; PRIORITY JOURNAL; SMOKING; VIROTHERAPY; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; FETAL GROWTH RETARDATION; HIV SEROPOSITIVITY; IMMUNOLOGY; MATERNAL AGE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRUS LOAD; YOUNG ADULT;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; FETAL GROWTH RETARDATION; FETUS; HIV SEROPOSITIVITY; HUMANS; IMMUNITY, CELLULAR; MATERNAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; SMOKING; VIRAL LOAD; YOUNG ADULT;

EID: 77954879009     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0030-1248937     Document Type: Article

References (10)

1. Bulterys M, Chao A, Munyemana S et al. Maternal human immunodeficiency virus 1 infection and intrauterine growth: a prospective cohort study in Butare, Rwanda. Pediatr Infect Dis J 1994 13 94-100
2. Ellis J, Williams H, Graves W, Lindsay M K. Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome. Am J Obstet Gynecol 2002 186 903-906
3. Gardosi J. Customized fetal growth standards: rationale and clinical application. Semin Perinatol 2004 28 33-40
4. Bukowski R, Burgett A D., Gei A, Saade G R., Hankins G D. Impairment of fetal growth potential and neonatal encephalopathy. Am J Obstet Gynecol 2003 188 1011-1015
5. Gardosi J. Customized growth curves. Clin Obstet Gynecol 1997 40 715-722
6. Goldstein P J., Smit R, Stevens M, Sever J L. Association between HIV in pregnancy and antiretroviral therapy, including protease inhibitors and low birth weight infants. Infect Dis Obstet Gynecol 2000 8 94-98
7. Markson L E., Turner B J., Houchens R, Silverman N S., Cosler L, Takyi B K. Association of maternal HIV infection with low birth weight. J Acquir Immune Defic Syndr Hum Retrovirol 1996 13 227-234
8. Stratton P, Tuomala R, Abboud R et al. Obstetric and newborn outcomes in a cohort of HIV infected pregnant women: a report of the women and infants transmission study. J Acquir Immune Defic Syndr Hum Retrovirol 1999 20 179-186
9. Lambert J S., Watts D H., Mofenson L et al. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team. AIDS 2000 14 1389-1399
10. Cooper E R., Charurat M, Mofenson L et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002 29 484-494